Palisade Bio Inc (NASDAQ: PALI) kicked off on Monday, up 7.04% from the previous trading day, before settling in for the closing price of $2.13. Over the past 52 weeks, PALI has traded in a range of $0.53-$3.30.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 77.35%. While this was happening, its average annual earnings per share was recorded 93.18%. With a float of $139.74 million, this company’s outstanding shares have now reached $149.00 million.
Palisade Bio Inc (PALI) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Palisade Bio Inc is 6.22%, while institutional ownership is 28.72%.
Palisade Bio Inc (PALI) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.69 earnings per share (EPS), higher than consensus estimate (set at -1.99) by 1.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 93.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.44% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Take a look at Palisade Bio Inc’s (PALI) current performance indicators. Last quarter, stock had a quick ratio of 1.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.22, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
The latest stats from [Palisade Bio Inc, PALI] show that its last 5-days average volume of 4.02 million was superior to 2.99 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 73.09%.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 91.15%, which indicates a significant increase from 81.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.62, while its 200-day Moving Average is $0.99. Now, the first resistance to watch is $2.35. This is followed by the second major resistance level at $2.43. The third major resistance level sits at $2.53. If the price goes on to break the first support level at $2.17, it is likely to go to the next support level at $2.06. Assuming the price breaks the second support level, the third support level stands at $1.99.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
The company with the Market Capitalisation of 339.73 million has total of 149,003K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -14,440 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,870 K.
